Agenus Inc. (AGEN)
USD 1.5
(-6.25%)
USD 1.5
(-6.25%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 137.32 Million USD | 80.9% |
| 2022 | 75.91 Million USD | 38.19% |
| 2021 | 54.93 Million USD | 3.75% |
| 2020 | 52.94 Million USD | 147.4% |
| 2019 | 21.4 Million USD | 61.98% |
| 2018 | 13.21 Million USD | -90.72% |
| 2017 | 142.38 Million USD | 9.07% |
| 2016 | 130.54 Million USD | 14.18% |
| 2015 | 114.32 Million USD | 2297.1% |
| 2014 | 4.76 Million USD | -10.81% |
| 2013 | 5.34 Million USD | -85.03% |
| 2012 | 35.71 Million USD | 9.13% |
| 2011 | 32.72 Million USD | -3.89% |
| 2010 | 34.05 Million USD | -31.2% |
| 2009 | 49.49 Million USD | -27.04% |
| 2008 | 67.83 Million USD | -12.36% |
| 2007 | 77.4 Million USD | 2.74% |
| 2006 | 75.33 Million USD | 171803.64% |
| 2005 | 43.82 Thousand USD | -99.03% |
| 2004 | 4.51 Million USD | -55.96% |
| 2003 | 10.24 Million USD | 88915.52% |
| 2002 | 11.5 Thousand USD | -94.07% |
| 2001 | 194 Thousand USD | -92.66% |
| 2000 | 2.64 Million USD | 20.13% |
| 1999 | 2.2 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 184.16 Million USD | -100.0% |
| 2024 Q1 | 125.24 Million USD | -8.79% |
| 2023 Q2 | 74.92 Million USD | -0.74% |
| 2023 Q1 | 75.48 Million USD | -0.56% |
| 2023 FY | 137.32 Million USD | 80.9% |
| 2023 Q3 | 75.88 Million USD | 1.28% |
| 2023 Q4 | 137.32 Million USD | 80.96% |
| 2022 FY | 75.91 Million USD | 38.19% |
| 2022 Q4 | 75.91 Million USD | 18.95% |
| 2022 Q3 | 63.81 Million USD | -1.17% |
| 2022 Q2 | 64.57 Million USD | 36.16% |
| 2022 Q1 | 47.42 Million USD | -13.67% |
| 2021 Q2 | 53.75 Million USD | -0.64% |
| 2021 Q1 | 54.1 Million USD | 2.18% |
| 2021 FY | 54.93 Million USD | 3.75% |
| 2021 Q3 | 51.68 Million USD | -3.85% |
| 2021 Q4 | 54.93 Million USD | 6.28% |
| 2020 Q4 | 52.94 Million USD | 56.83% |
| 2020 Q1 | 27.3 Million USD | 27.6% |
| 2020 Q2 | 34.15 Million USD | 25.06% |
| 2020 FY | 52.94 Million USD | 147.4% |
| 2020 Q3 | 33.75 Million USD | -1.15% |
| 2019 Q2 | 7.28 Million USD | 24.36% |
| 2019 Q3 | 8.24 Million USD | 13.16% |
| 2019 FY | 21.4 Million USD | 61.98% |
| 2019 Q4 | 21.4 Million USD | 159.55% |
| 2019 Q1 | 5.85 Million USD | -55.65% |
| 2018 FY | 13.21 Million USD | -90.72% |
| 2018 Q2 | 12.9 Million USD | 1.11% |
| 2018 Q4 | 13.21 Million USD | 1.21% |
| 2018 Q3 | 13.05 Million USD | 1.14% |
| 2018 Q1 | 12.76 Million USD | -91.03% |
| 2017 Q2 | 138.53 Million USD | 3.26% |
| 2017 Q4 | 142.38 Million USD | 15.49% |
| 2017 FY | 142.38 Million USD | 9.07% |
| 2017 Q1 | 134.15 Million USD | 2.77% |
| 2017 Q3 | 123.29 Million USD | -11.0% |
| 2016 Q3 | 126.26 Million USD | 3.39% |
| 2016 Q2 | 122.12 Million USD | 3.35% |
| 2016 Q1 | 118.16 Million USD | 3.35% |
| 2016 FY | 130.54 Million USD | 14.18% |
| 2016 Q4 | 130.54 Million USD | 3.39% |
| 2015 FY | 114.32 Million USD | 2297.1% |
| 2015 Q1 | 11.07 Million USD | 132.29% |
| 2015 Q4 | 114.32 Million USD | 3.41% |
| 2015 Q3 | 110.55 Million USD | 879.96% |
| 2015 Q2 | 11.28 Million USD | 1.83% |
| 2014 Q2 | - USD | -100.0% |
| 2014 Q1 | 5.27 Million USD | -1.31% |
| 2014 FY | 4.76 Million USD | -10.81% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q4 | 4.76 Million USD | 0.0% |
| 2013 Q4 | 5.34 Million USD | -11.85% |
| 2013 FY | 5.34 Million USD | -85.03% |
| 2013 Q2 | 6.79 Million USD | -81.2% |
| 2013 Q1 | 36.14 Million USD | 1.22% |
| 2013 Q3 | 6.06 Million USD | -10.75% |
| 2012 Q1 | 33.1 Million USD | 1.15% |
| 2012 Q4 | 35.71 Million USD | 1.19% |
| 2012 FY | 35.71 Million USD | 9.13% |
| 2012 Q3 | 35.29 Million USD | 0.87% |
| 2012 Q2 | 34.99 Million USD | 5.71% |
| 2011 FY | 32.72 Million USD | -3.89% |
| 2011 Q4 | 32.72 Million USD | 5.84% |
| 2011 Q3 | 30.92 Million USD | 1.52% |
| 2011 Q2 | 30.45 Million USD | 6.04% |
| 2011 Q1 | 28.72 Million USD | -15.65% |
| 2010 Q3 | 17.08 Million USD | -65.28% |
| 2010 Q1 | 49.79 Million USD | 0.61% |
| 2010 Q2 | 49.19 Million USD | -1.21% |
| 2010 Q4 | 34.05 Million USD | 99.35% |
| 2010 FY | 34.05 Million USD | -31.2% |
| 2009 Q2 | 48.86 Million USD | -22.62% |
| 2009 Q3 | 47.96 Million USD | -1.85% |
| 2009 Q4 | 49.49 Million USD | 3.19% |
| 2009 FY | 49.49 Million USD | -27.04% |
| 2009 Q1 | 63.15 Million USD | -6.9% |
| 2008 FY | 67.83 Million USD | -12.36% |
| 2008 Q4 | 67.83 Million USD | -13.58% |
| 2008 Q3 | 78.49 Million USD | 0.0% |
| 2008 Q2 | 78.49 Million USD | 1.42% |
| 2008 Q1 | 77.4 Million USD | 0.0% |
| 2007 Q3 | 76.34 Million USD | 0.0% |
| 2007 FY | 77.4 Million USD | 2.74% |
| 2007 Q1 | 75.33 Million USD | 0.0% |
| 2007 Q4 | 77.4 Million USD | 1.38% |
| 2007 Q2 | 76.34 Million USD | 1.35% |
| 2006 FY | 75.33 Million USD | 171803.64% |
| 2006 Q4 | 75.33 Million USD | 50.67% |
| 2006 Q3 | 50 Million USD | 0.0% |
| 2006 Q2 | 50 Million USD | 0.0% |
| 2006 Q1 | 50 Million USD | 113995.34% |
| 2005 Q1 | 53.04 Million USD | 1075.57% |
| 2005 Q4 | 43.82 Thousand USD | -99.91% |
| 2005 Q2 | 51.55 Million USD | -2.8% |
| 2005 FY | 43.82 Thousand USD | -99.03% |
| 2005 Q3 | 50.33 Million USD | -2.36% |
| 2004 Q2 | 7.4 Million USD | -11.79% |
| 2004 FY | 4.51 Million USD | -55.96% |
| 2004 Q3 | 5.96 Million USD | -19.45% |
| 2004 Q4 | 4.51 Million USD | -24.39% |
| 2004 Q1 | 8.39 Million USD | -18.03% |
| 2003 Q3 | 8.08 Million USD | 0.0% |
| 2003 Q1 | - USD | -100.0% |
| 2003 FY | 10.24 Million USD | 88915.52% |
| 2003 Q4 | 10.24 Million USD | 26.77% |
| 2003 Q2 | - USD | 0.0% |
| 2002 Q4 | 11.5 Thousand USD | 0.0% |
| 2002 Q1 | - USD | -100.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 FY | 11.5 Thousand USD | -94.07% |
| 2001 Q1 | 2.26 Million USD | -14.34% |
| 2001 Q2 | 1.48 Million USD | -34.21% |
| 2001 FY | 194 Thousand USD | -92.66% |
| 2001 Q4 | 194 Thousand USD | -77.78% |
| 2001 Q3 | 873.1 Thousand USD | -41.37% |
| 2000 Q2 | 1.7 Million USD | -11.92% |
| 2000 FY | 2.64 Million USD | 20.13% |
| 2000 Q3 | 1.46 Million USD | -14.04% |
| 2000 Q4 | 2.64 Million USD | 80.63% |
| 2000 Q1 | 1.93 Million USD | 0.0% |
| 1999 FY | 2.2 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | 71.22 Million USD | -92.811% |
| Alkermes plc | 287.73 Million USD | 52.273% |
| Alnylam Pharmaceuticals, Inc. | 2.34 Billion USD | 94.139% |
| Aptorum Group Limited | 3.05 Million USD | -4389.913% |
| Ardelyx, Inc. | 51.54 Million USD | -166.405% |
| Arrowhead Pharmaceuticals, Inc. | 104.6 Million USD | -31.275% |
| Bicycle Therapeutics plc | 40.08 Million USD | -242.625% |
| BioXcel Therapeutics, Inc. | 100.59 Million USD | -36.508% |
| ChromaDex Corporation | 2.57 Million USD | -5232.971% |
| Chimerix, Inc. | 125 Thousand USD | -109759.2% |
| Corbus Pharmaceuticals Holdings, Inc. | 3.23 Million USD | -4140.187% |
| Caribou Biosciences, Inc. | 25.9 Million USD | -430.045% |
| CRISPR Therapeutics AG | 223 Million USD | 38.422% |
| Precision BioSciences, Inc. | 7.72 Million USD | -1678.117% |
| Dyadic International, Inc. | 88.87 Thousand USD | -154422.336% |
| Eton Pharmaceuticals, Inc. | 22 Thousand USD | -624100.0% |
| Fortress Biotech, Inc. | 60.85 Million USD | -125.654% |
| Lantern Pharma Inc. | 61.49 Thousand USD | -223205.581% |
| HOOKIPA Pharma Inc. | 3.8 Million USD | -3512.839% |
| Inhibikase Therapeutics, Inc. | 90.12 Thousand USD | -152272.287% |
| Incyte Corporation | 29.16 Million USD | -370.9% |
| IO Biotech, Inc. | 1.83 Million USD | -7367.319% |
| Jaguar Health, Inc. | 30.99 Million USD | -343.081% |
| Novavax, Inc. | 168.01 Million USD | 18.267% |
| Janux Therapeutics, Inc. | 23.02 Million USD | -496.413% |
| Opthea Limited | 200.53 Million USD | 31.521% |
| Ligand Pharmaceuticals Incorporated | 5.75 Million USD | -2286.169% |
| ContextLogic Inc. | 6 Million USD | -2188.733% |
| MiMedx Group, Inc. | 48.09 Million USD | -185.503% |
| Pyxis Oncology, Inc. | 20.09 Million USD | -583.238% |
| TransCode Therapeutics, Inc. | 38.29 Thousand USD | -358532.577% |
| NextCure, Inc. | 5.94 Million USD | -2208.354% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Oncternal Therapeutics, Inc. | 145 Thousand USD | -94606.207% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Vaxcyte, Inc. | 22.11 Million USD | -521.066% |
| PDS Biotechnology Corporation | 19.5 Million USD | -604.002% |
| Madrigal Pharmaceuticals, Inc. | 115.48 Million USD | -18.916% |
| Pharming Group N.V. | 166.1 Million USD | 17.327% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avidity Biosciences, Inc. | 6.21 Million USD | -2110.269% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 33.51 Million USD | -309.739% |
| Sol-Gel Technologies Ltd. | 1.2 Million USD | -11286.733% |
| Acelyrin, Inc. | 1.19 Million USD | -11401.173% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | 460 Thousand USD | -29753.043% |
| Summit Therapeutics Inc. | 103.29 Million USD | -32.95% |
| Sensei Biotherapeutics, Inc. | 3.76 Million USD | -3543.513% |
| Senti Biosciences, Inc. | 33.53 Million USD | -309.458% |
| Stoke Therapeutics, Inc. | 4.77 Million USD | -2777.1% |
| Syros Pharmaceuticals, Inc. | 34.55 Million USD | -297.396% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 60.32 Million USD | -127.655% |
| VistaGen Therapeutics, Inc. | 1.57 Million USD | -8646.752% |
| Wave Life Sciences Ltd. | 25.4 Million USD | -440.561% |
| Sorrento Therapeutics, Inc. | 104.33 Million USD | -31.615% |
| TRACON Pharmaceuticals, Inc. | 732 Thousand USD | -18660.109% |
| Barinthus Biotherapeutics plc | 11.19 Million USD | -1127.093% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Phathom Pharmaceuticals, Inc. | 138.3 Million USD | 0.709% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Keros Therapeutics, Inc. | 13.43 Million USD | -921.832% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 15 Million USD | -815.493% |
| Xeris Biopharma Holdings, Inc. | 190.93 Million USD | 28.077% |
| Rigel Pharmaceuticals, Inc. | 52.65 Million USD | -160.785% |
| Fortress Biotech, Inc. | 60.85 Million USD | -125.654% |
| Precigen, Inc. | 5.89 Million USD | -2229.5% |
| Clearside Biomedical, Inc. | 41.98 Million USD | -227.055% |
| AlloVir, Inc. | 16.64 Million USD | -724.868% |
| C4 Therapeutics, Inc. | 65.75 Million USD | -108.836% |
| Fate Therapeutics, Inc. | 97.36 Million USD | -41.048% |
| ImmuCell Corporation | 10.54 Million USD | -1202.823% |
| IDEAYA Biosciences, Inc. | 1.12 Million USD | -12106.578% |
| Onconetix, Inc. | 118.85 Thousand USD | -115437.158% |
| PureTech Health plc | 18.25 Million USD | -652.46% |
| VYNE Therapeutics Inc. | 99 Thousand USD | -138611.111% |
| Elevation Oncology, Inc. | 30.13 Million USD | -355.666% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 25.96 Million USD | -428.902% |
| Verrica Pharmaceuticals Inc. | 42.87 Million USD | -220.297% |
| Innoviva, Inc. | 446.23 Million USD | 69.226% |
| Aadi Bioscience, Inc. | 833 Thousand USD | -16385.474% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| GlycoMimetics, Inc. | 66.84 Thousand USD | -205339.531% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 206.96 Million USD | 33.65% |
| Akebia Therapeutics, Inc. | 71.19 Million USD | -92.882% |
| Catalyst Pharmaceuticals, Inc. | 3.18 Million USD | -4207.528% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Orchestra BioMed Holdings, Inc. | 1.03 Million USD | -13129.672% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | 22.32 Million USD | -515.086% |
| Aptose Biosciences Inc. | 621 Thousand USD | -22013.366% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 1.01 Million USD | -13483.874% |
| Century Therapeutics, Inc. | 46.65 Million USD | -194.32% |
| Kura Oncology, Inc. | 9.33 Million USD | -1371.539% |
| TScan Therapeutics, Inc. | 26.7 Million USD | -414.322% |
| Intensity Therapeutics, Inc. | 138 Thousand USD | -99410.145% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 9.38 Million USD | -1363.229% |
| Autolus Therapeutics plc | 47.91 Million USD | -186.605% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 4.9 Million USD | -2699.103% |
| Eterna Therapeutics Inc. | 6.77 Million USD | -1927.521% |
| Adaptive Biotechnologies Corporation | 130.66 Million USD | -5.1% |
| GRI Bio, Inc. | - USD | -Infinity% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 8.1 Million USD | -1594.312% |
| IGM Biosciences, Inc. | 34.67 Million USD | -296.066% |
| INmune Bio, Inc. | 397 Thousand USD | -34490.428% |
| Heron Therapeutics, Inc. | 173.75 Million USD | 20.966% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -3287.153% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | 146.94 Thousand USD | -93350.109% |
| Milestone Pharmaceuticals Inc. | 49.77 Million USD | -175.906% |
| X4 Pharmaceuticals, Inc. | 54.57 Million USD | -151.647% |
| Atara Biotherapeutics, Inc. | 45.69 Million USD | -200.536% |
| Coherus BioSciences, Inc. | 473.36 Million USD | 70.99% |
| Verastem, Inc. | 40.08 Million USD | -242.573% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -3019.582% |
| Pliant Therapeutics, Inc. | 10.05 Million USD | -1265.864% |
| Tonix Pharmaceuticals Holding Corp. | 6.56 Million USD | -1993.035% |
| Histogen Inc. | 4.38 Million USD | -3032.391% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 882 Thousand USD | -15469.615% |
| Organovo Holdings, Inc. | 888 Thousand USD | -15364.414% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 30 Million USD | -357.747% |
| Panbela Therapeutics, Inc. | 4.19 Million USD | -3174.297% |
| CASI Pharmaceuticals, Inc. | 18.89 Million USD | -626.774% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 75.7 Million USD | -81.406% |
| Hepion Pharmaceuticals, Inc. | 93.1 Thousand USD | -147395.274% |
| Arcturus Therapeutics Holdings Inc. | 25.9 Million USD | -430.065% |
| BioRestorative Therapies, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 267 Thousand USD | -51332.21% |
| Amarin Corporation plc | 8.73 Million USD | -1471.752% |
| Mesoblast Limited | 100.48 Million USD | -36.664% |
| Turnstone Biologics Corp. | 1.18 Million USD | -11449.537% |
| Kymera Therapeutics, Inc. | 78.32 Million USD | -75.317% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 109 Thousand USD | -125885.321% |
| Aurinia Pharmaceuticals Inc. | 82 Million USD | -67.45% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | 27.703% |
| Better Therapeutics, Inc. | 10.34 Million USD | -1227.058% |
| Nurix Therapeutics, Inc. | 23.12 Million USD | -493.834% |
| Apellis Pharmaceuticals, Inc. | 93.03 Million USD | -47.608% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 1.29 Million USD | -10528.793% |
| Gritstone bio, Inc. | 40.14 Million USD | -242.079% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -7470.232% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 153.59 Million USD | 10.592% |
| Insmed Incorporated | 1.19 Billion USD | 88.493% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.35 Million USD | -2062.583% |
| OmniAb, Inc. | 22.07 Million USD | -522.079% |
| Alector, Inc. | 30.45 Million USD | -350.893% |
| Seres Therapeutics, Inc. | 101.54 Million USD | -35.236% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 8.04 Million USD | -1606.524% |
| Revance Therapeutics, Inc. | 426.59 Million USD | 67.809% |
| Aura Biosciences, Inc. | 16.87 Million USD | -714.013% |
| Lyell Immunopharma, Inc. | 56.89 Million USD | -141.368% |
| Immunic, Inc. | 639 Thousand USD | -21390.454% |
| Tarsus Pharmaceuticals, Inc. | 29.81 Million USD | -360.525% |
| Veracyte, Inc. | 7.52 Million USD | -1724.904% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 78.705% |
| FibroGen, Inc. | 89.69 Million USD | -53.098% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -3066.336% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 130.86 Thousand USD | -104837.224% |
| Jazz Pharmaceuticals plc | 5.1 Billion USD | 97.312% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -371045.946% |
| Amylyx Pharmaceuticals, Inc. | 1.98 Million USD | -6835.556% |
| TG Therapeutics, Inc. | 100.11 Million USD | -37.162% |
| Galecto, Inc. | 66 Thousand USD | -207966.667% |
| Calithera Biosciences, Inc. | 136 Thousand USD | -100873.529% |
| Fortrea Holdings Inc. | 1.63 Billion USD | 91.588% |
| KalVista Pharmaceuticals, Inc. | 6.01 Million USD | -2183.026% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -2444.451% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -7470.232% |
| Lyra Therapeutics, Inc. | 21.44 Million USD | -540.295% |
| Foghorn Therapeutics Inc. | 36.55 Million USD | -275.664% |
| Y-mAbs Therapeutics, Inc. | 517 Thousand USD | -26461.702% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -203.572% |
| Ultragenyx Pharmaceutical Inc. | 30.57 Million USD | -349.153% |
| Metagenomi, Inc. Common Stock | 44.8 Million USD | -206.513% |
| Vaxxinity, Inc. | 13.26 Million USD | -935.47% |
| BioCryst Pharmaceuticals, Inc. | 811.26 Million USD | 83.073% |
| Gain Therapeutics, Inc. | 449.05 Thousand USD | -30480.8% |
| Cartesian Therapeutics, Inc. | 8.78 Million USD | -1462.453% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | - USD | -Infinity% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 94.919% |
| Chemomab Therapeutics Ltd. | 316 Thousand USD | -43356.962% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | 4.45 Million USD | -2980.395% |
| Ainos, Inc. | 5.92 Million USD | -2219.053% |
| Pluri Inc. | 29.05 Million USD | -372.667% |
| Prothena Corporation plc | 10.72 Million USD | -1180.888% |
| Adaptimmune Therapeutics plc | 19.85 Million USD | -591.774% |
| Celularity Inc. | 26.17 Million USD | -424.598% |
| Rallybio Corporation | 173 Thousand USD | -79278.035% |
| Cue Biopharma, Inc. | 4.2 Million USD | -3168.063% |
| MeiraGTx Holdings plc | 72.11 Million USD | -90.413% |
| Omeros Corporation | 329.7 Million USD | 58.349% |
| Humacyte, Inc. | 38.6 Million USD | -255.762% |
| Immunocore Holdings plc | 82.64 Million USD | -66.163% |
| Cocrystal Pharma, Inc. | 1.61 Million USD | -8413.577% |
| Cidara Therapeutics, Inc. | 3.57 Million USD | -3739.083% |
| Blueprint Medicines Corporation | 610.96 Million USD | 77.523% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 1.45 Million USD | -9318.656% |
| Marinus Pharmaceuticals, Inc. | 95.18 Million USD | -44.265% |
| Scholar Rock Holding Corporation | 48.68 Million USD | -182.072% |
| Sana Biotechnology, Inc. | 90.9 Million USD | -51.07% |
| Pulmatrix, Inc. | 8.32 Million USD | -1549.141% |
| Elicio Therapeutics, Inc. | 6 Million USD | -2186.066% |
| Vigil Neuroscience, Inc. | 12.94 Million USD | -960.827% |
| Intellia Therapeutics, Inc. | 96.74 Million USD | -41.941% |
| Adlai Nortye Ltd. American Depositary Shares | 469 Thousand USD | -29180.171% |
| Cytokinetics, Incorporated | 607.37 Million USD | 77.39% |
| Eloxx Pharmaceuticals, Inc. | 8.69 Million USD | -1479.89% |
| Nutriband Inc. | 79.82 Thousand USD | -171929.163% |
| Protara Therapeutics, Inc. | 4.48 Million USD | -2962.533% |
| Vor Biopharma Inc. | 31.83 Million USD | -331.429% |
| Roivant Sciences Ltd. | 477.85 Million USD | 71.262% |
| Evogene Ltd. | 10.65 Million USD | -1189.064% |
| ProKidney Corp. | 3.61 Million USD | -3703.989% |
| Applied Therapeutics, Inc. | 759 Thousand USD | -17992.754% |
| Hoth Therapeutics, Inc. | 26.32 Thousand USD | -521528.808% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 92.088% |
| CorMedix Inc. | 517.01 Thousand USD | -26461.034% |
| BioLineRx Ltd. | 6.62 Million USD | -1971.877% |
| Tango Therapeutics, Inc. | 36.83 Million USD | -272.778% |
| Galectin Therapeutics Inc. | 71.74 Million USD | -91.416% |
| Atai Life Sciences N.V. | 15.21 Million USD | -802.794% |
| Renovaro Biosciences Inc. | 842.38 Thousand USD | -16201.732% |
| Aerovate Therapeutics, Inc. | 255 Thousand USD | -53752.549% |
| Zentalis Pharmaceuticals, Inc. | 43.15 Million USD | -218.248% |
| Sagimet Biosciences Inc. | - USD | -Infinity% |
| MediciNova, Inc. | 410.66 Thousand USD | -33339.829% |
| Praxis Precision Medicines, Inc. | 1.36 Million USD | -9930.972% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -20609.426% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 178.07 Million USD | 22.882% |
| Biomea Fusion, Inc. | 7.83 Million USD | -1653.819% |
| PTC Therapeutics, Inc. | 284.21 Million USD | 51.683% |
| Mereo BioPharma Group plc | 5.3 Million USD | -2491.019% |
| Cullinan Oncology, Inc. | 2.15 Million USD | -6287.163% |
| Syndax Pharmaceuticals, Inc. | 588 Thousand USD | -23254.422% |
| Absci Corporation | 4.66 Million USD | -2846.867% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 11.52 Million USD | -1091.842% |
| Dyne Therapeutics, Inc. | 22.69 Million USD | -505.085% |
| Kiniksa Pharmaceuticals, Ltd. | 10 Million USD | -1272.554% |
| Ventyx Biosciences, Inc. | 11.5 Million USD | -1093.603% |
| Allakos Inc. | 38.21 Million USD | -259.346% |
| Imunon, Inc. | 1.13 Million USD | -11953.44% |
| Fulcrum Therapeutics, Inc. | 8.62 Million USD | -1491.424% |
| Corcept Therapeutics Incorporated | - USD | -Infinity% |
| BioAtla, Inc. | 836 Thousand USD | -16326.316% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | 10 Thousand USD | -1373140.0% |
| Allogene Therapeutics, Inc. | 88.34 Million USD | -55.439% |
| Larimar Therapeutics, Inc. | 4.7 Million USD | -2816.203% |
| XOMA Corporation | 118.51 Million USD | -15.868% |
| Kezar Life Sciences, Inc. | 10.06 Million USD | -1263.83% |
| Cara Therapeutics, Inc. | 37.07 Million USD | -270.355% |
| aTyr Pharma, Inc. | 13.76 Million USD | -897.487% |
| Aligos Therapeutics, Inc. | 7.89 Million USD | -1638.499% |
| Akero Therapeutics, Inc. | 24.96 Million USD | -450.088% |
| Viridian Therapeutics, Inc. | 20.2 Million USD | -579.654% |
| Eliem Therapeutics, Inc. | 15 Thousand USD | -915393.333% |
| EyeGate Pharmaceuticals, Inc. | 278.19 Thousand USD | -49263.385% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -850.02% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 90.84% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -100745.248% |
| UroGen Pharma Ltd. | 98.55 Million USD | -39.343% |
| Sutro Biopharma, Inc. | 149.11 Million USD | 7.907% |
| ZIVO Bioscience, Inc. | - USD | -Infinity% |
| Orgenesis Inc. | 19.06 Million USD | -620.218% |
| Entera Bio Ltd. | 256 Thousand USD | -53542.188% |
| GH Research PLC | 631 Thousand USD | -21662.916% |
| Lisata Therapeutics, Inc. | 137.00 USD | -100236396.35% |
| Reneo Pharmaceuticals, Inc. | 642 Thousand USD | -21290.031% |
| Xencor, Inc. | 14.64 Million USD | -837.877% |
| 60 Degrees Pharmaceuticals, Inc. | 150.25 Thousand USD | -91296.397% |
| Replimune Group, Inc. | 71.99 Million USD | -90.754% |
| Coeptis Therapeutics Holdings, Inc. | 150 Thousand USD | -91449.333% |
| Vanda Pharmaceuticals Inc. | 7 Million USD | -1860.091% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -100745.248% |
| Portage Biotech Inc. | 7000.00 USD | -1961671.429% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -20609.426% |
| Olema Pharmaceuticals, Inc. | 1.42 Million USD | -9509.797% |
| OncoCyte Corporation | 2.2 Million USD | -6130.672% |
| Qualigen Therapeutics, Inc. | - USD | -Infinity% |
| Processa Pharmaceuticals, Inc. | 66.9 Thousand USD | -205152.223% |
| Purple Biotech Ltd. | 163 Thousand USD | -84147.853% |
| CollPlant Biotechnologies Ltd. | 2.53 Million USD | -5317.12% |
| scPharmaceuticals Inc. | 38.81 Million USD | -253.828% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 25.24 Million USD | -443.987% |
| NeuroSense Therapeutics Ltd. | 73 Thousand USD | -188015.068% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 1.85 Million USD | -7310.901% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.34 Million USD | -421.193% |
| Curis, Inc. | 1.48 Million USD | -9122.565% |
| Daré Bioscience, Inc. | 3.91 Million USD | -3408.824% |
| Carmell Therapeutics Corporation | 697.71 Thousand USD | -19581.962% |
| Titan Pharmaceuticals, Inc. | - USD | -Infinity% |
| Achieve Life Sciences, Inc. | 6000.00 USD | -2288633.333% |
| BeiGene, Ltd. | 197.61 Million USD | 30.51% |
| Kiromic BioPharma, Inc. | 911.5 Thousand USD | -14965.716% |
| Revolution Medicines, Inc. Warrant | 80.57 Million USD | -70.43% |
| Protagonist Therapeutics, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 51.88 Million USD | -164.65% |
| bluebird bio, Inc. | 224.41 Million USD | 38.809% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 593.09 Million USD | 76.846% |
| DBV Technologies S.A. | 4.52 Million USD | -2934.114% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 1.34 Million USD | -10148.06% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 9.74 Million USD | -1309.608% |
| Acrivon Therapeutics, Inc. Common Stock | 3.76 Million USD | -3545.447% |
| Travere Therapeutics, Inc. | 377.26 Million USD | 63.6% |
| Monte Rosa Therapeutics, Inc. | 42.87 Million USD | -220.274% |
| Spruce Biosciences, Inc. | 1.71 Million USD | -7897.903% |
| Celldex Therapeutics, Inc. | 928 Thousand USD | -14697.845% |
| Cogent Biosciences, Inc. | 17.46 Million USD | -686.191% |
| MacroGenics, Inc. | 30.19 Million USD | -354.775% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 17.7 Million USD | -675.71% |
| Prime Medicine, Inc. | 4.35 Million USD | -3051.802% |
| Aditxt, Inc. | 1.04 Million USD | -13082.125% |
| Adagene Inc. | 13.54 Million USD | -914.207% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -899.665% |
| Maravai LifeSciences Holdings, Inc. | 518.7 Million USD | 73.526% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 17.09 Million USD | -703.393% |
| SciSparc Ltd. | 24 Thousand USD | -572083.333% |
| Vericel Corporation | 81.85 Million USD | -67.763% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -67.434% |
| Generation Bio Co. | 89.77 Million USD | -52.966% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | 22.18 Million USD | -518.995% |
| Arcutis Biotherapeutics, Inc. | 201.79 Million USD | 31.95% |
| Invivyd, Inc. | 722 Thousand USD | -18919.945% |
| Relay Therapeutics, Inc. | 48.5 Million USD | -183.131% |
| Quoin Pharmaceuticals, Ltd. | 2923.73 USD | -4696776.935% |
| Spero Therapeutics, Inc. | 3.82 Million USD | -3490.17% |
| Artelo Biosciences, Inc. | 23 Thousand USD | -596960.87% |
| 2seventy bio, Inc. | 244.01 Million USD | 43.723% |
| ADMA Biologics, Inc. | 130.59 Million USD | -5.153% |
| Clene Inc. | 7.15 Million USD | -1820.078% |
| Capricor Therapeutics, Inc. | 3.37 Million USD | -3967.342% |
| Boundless Bio, Inc. Common Stock | 247.61 Million USD | 44.542% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 1.1 Million USD | -12372.661% |
| Citius Pharmaceuticals, Inc. | 262.86 Thousand USD | -52141.265% |
| Contineum Therapeutics, Inc. Class A Common Stock | 192.62 Million USD | 28.707% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 28.4 Million USD | -383.484% |
| ALX Oncology Holdings Inc. | 9.63 Million USD | -1324.671% |
| Vir Biotechnology, Inc. | 111.67 Million USD | -22.97% |
| Evaxion Biotech A/S | 8.48 Million USD | -1517.718% |
| Ocular Therapeutix, Inc. | 74.92 Million USD | -83.282% |
| Verve Therapeutics, Inc. | 64.71 Million USD | -112.198% |
| Trevena, Inc. | 35.23 Million USD | -289.76% |
| Surrozen, Inc. | 882 Thousand USD | -15469.615% |
| Tyra Biosciences, Inc. | 6.21 Million USD | -2109.202% |
| Cingulate Inc. | 135.09 Thousand USD | -101546.94% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | 23.53 Million USD | -483.389% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 47.8 Million USD | -187.289% |
| Connect Biopharma Holdings Limited | 180 Thousand USD | -76191.111% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 25.37 Million USD | -441.093% |
| Bolt Biotherapeutics, Inc. | 17.43 Million USD | -687.544% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | 936 Thousand USD | -14571.368% |
| Statera Biopharma, Inc. | 11.43 Million USD | -1101.315% |
| ImmunityBio, Inc. | 836.95 Million USD | 83.592% |
| Korro Bio, Inc. | 31.21 Million USD | -339.915% |
| Kineta, Inc. | 150 Thousand USD | -91449.333% |
| BioVie Inc. | 349.89 Thousand USD | -39147.315% |
| Codexis, Inc. | 12.24 Million USD | -1021.653% |
| Celularity Inc. | 26.17 Million USD | -424.598% |
| Crinetics Pharmaceuticals, Inc. | 47.55 Million USD | -188.769% |
| Celcuity Inc. | 37.03 Million USD | -270.791% |
| Virax Biolabs Group Limited | 176.34 Thousand USD | -77772.352% |
| Cibus, Inc. | 17.67 Million USD | -676.983% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | 3.37 Million USD | -3964.043% |
| Kodiak Sciences Inc. | 100 Million USD | -37.324% |
| Annexon, Inc. | 29.19 Million USD | -370.449% |
| Adverum Biotechnologies, Inc. | 64.62 Million USD | -112.487% |
| Assembly Biosciences, Inc. | 1.12 Million USD | -12139.216% |
| Avalo Therapeutics, Inc. | 2 Million USD | -6766.2% |
| Ionis Pharmaceuticals, Inc. | 1.4 Billion USD | 90.194% |
| Eyenovia, Inc. | 8.95 Million USD | -1433.108% |
| Puma Biotechnology, Inc. | 65.65 Million USD | -109.147% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | 8.14 Million USD | -1586.613% |
| Arcellx, Inc. | 50.84 Million USD | -170.105% |
| Cardiff Oncology, Inc. | 1.45 Million USD | -9318.656% |
| Enanta Pharmaceuticals, Inc. | 21.23 Million USD | -546.596% |
| Regulus Therapeutics Inc. | 1.05 Million USD | -12916.493% |
| Moolec Science SA | 99.04 Thousand USD | -138546.689% |
| Acumen Pharmaceuticals, Inc. | 27.62 Million USD | -397.172% |
| Geron Corporation | 35.05 Million USD | -291.783% |
| LAVA Therapeutics N.V. | 591 Thousand USD | -23135.871% |
| Royalty Pharma plc | 6.13 Billion USD | 97.762% |
| Atea Pharmaceuticals, Inc. | 1.64 Million USD | -8263.216% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 31.74 Thousand USD | -432525.543% |
| Mersana Therapeutics, Inc. | 23.14 Million USD | -493.243% |
| Humacyte, Inc. | 38.6 Million USD | -255.762% |
| Structure Therapeutics Inc. | 4.01 Million USD | -3321.979% |
| 89bio, Inc. | 24.79 Million USD | -453.837% |
| PMV Pharmaceuticals, Inc. | 12.43 Million USD | -1004.423% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 1.86 Million USD | -7259.271% |
| Trevi Therapeutics, Inc. | 1.03 Million USD | -13206.589% |
| Lexicon Pharmaceuticals, Inc. | 99.5 Million USD | -38.003% |
| Notable Labs, Ltd. | 1.52 Million USD | -8898.952% |
| Liquidia Corporation | 2.36 Million USD | -5708.968% |
| Mustang Bio, Inc. | 1.97 Million USD | -6842.568% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -899.665% |
| Arbutus Biopharma Corporation | 6.95 Million USD | -1875.032% |
| DiaMedica Therapeutics Inc. | 317 Thousand USD | -43219.874% |
| Vera Therapeutics, Inc. | 49.87 Million USD | -175.325% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | 9.6 Million USD | -1329.863% |
| Elevai Labs, Inc. Common Stock | 65.48 Thousand USD | -209590.177% |
| NeuroBo Pharmaceuticals, Inc. | 136 Thousand USD | -100873.529% |
| Tempest Therapeutics, Inc. | 6.26 Million USD | -2092.273% |
| Soleno Therapeutics, Inc. | 130 Thousand USD | -105533.846% |
| PepGen Inc. | 17.1 Million USD | -703.064% |
| Moleculin Biotech, Inc. | 474 Thousand USD | -28871.308% |
| United Therapeutics Corporation | 300 Million USD | 54.225% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 23.94 Million USD | -473.593% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.16 Million USD | -3198.796% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 578 Thousand USD | -23658.478% |
| XOMA Corporation | 118.51 Million USD | -15.868% |
| ARS Pharmaceuticals, Inc. | 37 Thousand USD | -371045.946% |
| Bionomics Limited | 117.62 Million USD | -16.744% |
| Apogee Therapeutics, Inc. | 933 Thousand USD | -14618.542% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -2347.843% |
| uniQure N.V. | 130.06 Million USD | -5.581% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 58.59 Million USD | -134.381% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 686 Thousand USD | -19918.076% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -3066.336% |
| FibroBiologics, Inc. Common Stock | 1.38 Million USD | -9815.09% |
| Altimmune, Inc. | 175 Thousand USD | -78370.857% |
| Amicus Therapeutics, Inc. | 387.85 Million USD | 64.594% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -2347.843% |
| Compugen Ltd. | 719 Thousand USD | -18999.305% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Zevra Therapeutics, Inc. | 5.06 Million USD | -2610.699% |
| Benitec Biopharma Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -62.408% |
| NKGen Biotech, Inc. Common Stock | 9.93 Million USD | -1282.92% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 6.37 Million USD | -2052.751% |
| Aileron Therapeutics, Inc. | 91.41 Million USD | -50.229% |
| NKGen Biotech, Inc. Warrants | 9.93 Million USD | -1282.92% |
| Instil Bio, Inc. | 81.42 Million USD | -68.647% |
| argenx SE | 15.35 Million USD | -794.386% |
| Immunome, Inc. | 1.34 Million USD | -10148.06% |
| Compass Therapeutics, Inc. | 536 Thousand USD | -25520.149% |
| Verona Pharma plc | 48.37 Million USD | -183.88% |
| enGene Holdings Inc. Warrants | 9.21 Million USD | -1390.061% |
| Shattuck Labs, Inc. | 3.4 Million USD | -3931.826% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 85 Thousand USD | -161457.647% |
| Dianthus Therapeutics, Inc. | 168 Thousand USD | -81640.476% |
| Moolec Science SA | 99.04 Thousand USD | -138546.689% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 11.03 Million USD | -1144.771% |
| AnaptysBio, Inc. | 16.03 Million USD | -756.295% |
| Design Therapeutics, Inc. | 2.33 Million USD | -5783.633% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 27.07 Thousand USD | -507173.466% |
| Seelos Therapeutics, Inc. | - USD | -Infinity% |
| Lumos Pharma, Inc. | 6 Million USD | -2188.733% |
| Achilles Therapeutics plc | 1.07 Million USD | -12662.454% |
| enGene Holdings Inc. Common Stock | 9.21 Million USD | -1390.061% |
| 180 Life Sciences Corp. | 19.93 Thousand USD | -688724.238% |
| Opiant Pharmaceuticals, Inc. | 16.74 Million USD | -720.215% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 79.82 Thousand USD | -171929.163% |
| ORIC Pharmaceuticals, Inc. | 7461.00 USD | -1840457.566% |
| CG Oncology, Inc. Common stock | 13 Thousand USD | -1056238.462% |
| Fractyl Health, Inc. Common Stock | 342.48 Million USD | 59.903% |
| Rani Therapeutics Holdings, Inc. | 24.48 Million USD | -460.872% |
| MoonLake Immunotherapeutics | 2.49 Million USD | -5392.982% |
| Palisade Bio, Inc. | 90 Thousand USD | -152482.222% |
| Tourmaline Bio, Inc. | 194 Thousand USD | -70685.567% |
| Beam Therapeutics Inc. | 159.91 Million USD | 14.125% |
| Neurogene Inc. | 13.37 Million USD | -926.875% |
| Mirum Pharmaceuticals, Inc. | 306.42 Million USD | 55.185% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 26.26 Million USD | -422.88% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 59.82 Thousand USD | -229454.345% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -13632.4% |
| Taysha Gene Therapies, Inc. | 40.5 Million USD | -239.005% |
| Athira Pharma, Inc. | 1.21 Million USD | -11183.813% |
| Vaccinex, Inc. | 26 Thousand USD | -528069.231% |
| HCW Biologics Inc. | 6.3 Million USD | -2078.253% |
| XOMA Corporation | 118.51 Million USD | -15.868% |
| Nektar Therapeutics | 112.62 Million USD | -21.93% |
| Arvinas, Inc. | 800 Thousand USD | -17065.5% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -850.02% |
| Merus N.V. | 10.48 Million USD | -1209.344% |
| Omega Therapeutics, Inc. | 14.88 Million USD | -822.566% |
| Quince Therapeutics, Inc. | 13.42 Million USD | -922.593% |
| Rezolute, Inc. | 1.66 Million USD | -8172.53% |
| Clene Inc. | 7.15 Million USD | -1820.078% |
| Indaptus Therapeutics, Inc. | 73.34 Thousand USD | -187122.555% |
| BeyondSpring Inc. | 3.36 Million USD | -3982.164% |
| Synlogic, Inc. | 12.49 Million USD | -999.384% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Werewolf Therapeutics, Inc. | 32.65 Million USD | -320.517% |
| Krystal Biotech, Inc. | 6.62 Million USD | -1974.381% |
| Karyopharm Therapeutics Inc. | 170.91 Million USD | 19.656% |
| SpringWorks Therapeutics, Inc. | 5.99 Million USD | -2190.26% |
| Lipella Pharmaceuticals Inc. | 47.37 Thousand USD | -289790.439% |
| MannKind Corporation | 252.15 Million USD | 45.539% |
| Ikena Oncology, Inc. | 7.18 Million USD | -1812.591% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 199 Thousand USD | -68907.035% |
| Gossamer Bio, Inc. | 197.4 Million USD | 30.435% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 520 Thousand USD | -26308.462% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 281.32 Million USD | 51.187% |
| Mural Oncology plc | 8.91 Million USD | -1441.062% |
| Biora Therapeutics, Inc. | 43.73 Million USD | -213.984% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 1.43 Million USD | -9462.953% |
| Champions Oncology, Inc. | 6.09 Million USD | -2153.799% |
| REGENXBIO Inc. | 82.22 Million USD | -67.016% |
| Ensysce Biosciences, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 494 Thousand USD | -27698.212% |
| Edgewise Therapeutics, Inc. | 4.43 Million USD | -2997.068% |
| Vaxart, Inc. | 2.62 Million USD | -5135.379% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 271.63 Thousand USD | -50455.349% |
| Cellectis S.A. | 36.24 Million USD | -278.919% |
| Longeveron Inc. | 1.44 Million USD | -9383.702% |
| Repare Therapeutics Inc. | 1.01 Million USD | -13496.436% |
| Sarepta Therapeutics, Inc. | 1.13 Billion USD | 87.874% |
| Inozyme Pharma, Inc. | 44.76 Million USD | -206.739% |
| Revolution Medicines, Inc. | 80.57 Million USD | -70.43% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | 3.2 Million USD | -4180.673% |
| ArriVent BioPharma, Inc. Common Stock | 177 Thousand USD | -77484.181% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 123 Thousand USD | -111545.528% |
| Vertex Pharmaceuticals Incorporated | 724.7 Million USD | 81.051% |
| Denali Therapeutics Inc. | 44.98 Million USD | -205.293% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 12.5 Million USD | -998.219% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -101546.94% |
| Passage Bio, Inc. | 22.92 Million USD | -499.119% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.03 Million USD | -2173.953% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 647 Thousand USD | -21124.73% |
| Scinai Immunotherapeutics Ltd. | 20.16 Million USD | -581.002% |
| Rhythm Pharmaceuticals, Inc. | 490 Thousand USD | -27925.306% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 407.45 Thousand USD | -33602.697% |
| Carisma Therapeutics, Inc. | 1.18 Million USD | -11459.259% |
| Unicycive Therapeutics, Inc. | 466 Thousand USD | -29368.67% |
| OmniAb, Inc. | 22.07 Million USD | -522.079% |
| Anew Medical, Inc. | 1.54 Million USD | -8817.143% |
| Fennec Pharmaceuticals Inc. | 29.55 Million USD | -364.56% |
| Lipocine Inc. | - USD | -Infinity% |
| Lexeo Therapeutics, Inc. Common Stock | 9.03 Million USD | -1420.248% |
| Nautilus Biotechnology, Inc. | 31.09 Million USD | -341.698% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -3287.153% |
| G1 Therapeutics, Inc. | 51.55 Million USD | -166.354% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | - USD | -Infinity% |
| Ocugen, Inc. | 6.36 Million USD | -2056.809% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -871.93% |
| Q32 Bio Inc. | - USD | -Infinity% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -20335.119% |
| Alumis Inc. Common Stock | 30.86 Million USD | -344.99% |
| Equillium, Inc. | 384 Thousand USD | -35661.458% |
| Kyverna Therapeutics, Inc. | 6.15 Million USD | -2129.648% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | 151.04 Million USD | 9.086% |
| Evelo Biosciences, Inc. | 48.87 Million USD | -180.947% |
| Comera Life Sciences Holdings, Inc. | 120.3 Thousand USD | -114049.391% |
| Dominari Holdings Inc. | 3.02 Million USD | -4435.139% |
| Edesa Biotech, Inc. | 19.77 Thousand USD | -694402.605% |
| vTv Therapeutics Inc. | 169 Thousand USD | -81156.805% |
| Bio-Techne Corporation | 319 Million USD | 56.952% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | -140.97% |
| Harmony Biosciences Holdings, Inc. | 178.56 Million USD | 23.096% |
| Prelude Therapeutics Incorporated | 15.4 Million USD | -791.309% |
| Candel Therapeutics, Inc. | 12.38 Million USD | -1008.972% |
| iTeos Therapeutics, Inc. | 4.8 Million USD | -2756.751% |
| Nkarta, Inc. | 82.27 Million USD | -66.919% |
| BioCardia, Inc. | 982 Thousand USD | -13884.114% |
| Iterum Therapeutics plc | 18.95 Million USD | -624.436% |